Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
109 studies found for:    Open Studies | "Vasculitis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Vasculitis" (109 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Endothelin Antagonism in ANCA Vasculitis
Condition: Vasculitis
Intervention: Drug: BQ123 or BQ123/788
2 Recruiting A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
Condition: ANCA-Associated Vasculitis
Interventions: Drug: CCX168;   Drug: Prednisone;   Drug: Cyclophosphamide;   Biological: Rituximab;   Drug: Azathioprine
3 Recruiting IgA-positive Versus IgA-negative Immune Complex Vasculitis
Condition: Cutaneous Vasculitis
Intervention:
4 Recruiting MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS
Condition: ANCA-associated Vasculitis
Intervention: Other: Non interventional study
5 Recruiting Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Intervention: Drug: Rituximab
6 Recruiting Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Condition: ANCA-associated Primary Necrotizing Vasculitides
Interventions: Drug: Rosuvastatin;   Drug: Placebo
7 Recruiting Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis
Conditions: Pneumococcal Infection;   ANCA-associated Vasculitis
Intervention:
8 Recruiting Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
Conditions: Cryoglobulinemia;   Systemic Vasculitis
Interventions: Drug: rituximab;   Drug: Prednisone;   Drug: Placebo
9 Not yet recruiting Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Conditions: Uveitis, Posterior;   Vasculitis Retinal
Intervention: Drug: H.P. ACTHAR GEL
10 Recruiting A Randomized Multicenter Study for Isolated Skin Vasculitis
Conditions: Primary Cutaneous Vasculitis;   Cutaneous Polyarteritis Nodosa;   IgA Vasculitis;   Henoch-Schönlein Purpura
Interventions: Drug: Colchicine;   Drug: Dapsone;   Drug: Azathioprine
11 Recruiting The Clinical Efficacy of DFPP in Patients With AAGN
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions: Other: DFPP&CTX;   Drug: CTX
12 Recruiting Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis
Conditions: Vasculitis;   Cryoglobulinemia;   Hepatitis C
Intervention: Drug: new antiviral therapy
13 Recruiting Low-dose Glucocorticoid Vasculitis Induction Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Drug: Rituximab;   Drug: Glucocorticoids
14 Not yet recruiting Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
Conditions: ANCA-associated Vasculitis;   Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   EosinphilicGranulomatosis With Polyangiitis
Intervention:
15 Recruiting Vasculitis Pregnancy Registry
Conditions: Vasculitis;   Behcet's Disease;   CNS Vasculitis;   Cryoglobulinemic Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis (EGPA);   Churg-Strauss Syndrome (CSS);   Granulomatosis With Polyangiitis (GPA);   Wegener's Granulomatosis;   IgA Vasculitis;   Henoch-Schoenlein Purpura (HSP);   Microscopic Polyangiitis (MPA);   Polyarteritis Nodosa (PAN);   Takayasu Arteritis (TAK);   Urticarial Vasculitis;   Systemic Vasculitis
Intervention: Other: Online questionnaires
16 Recruiting Pediatric Vasculitis Initiative
Conditions: Wegeners Granulomatosis (Granulomatosis With Polyangiitis);   Microscopic Polyangiitis;   Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis);   Polyarteritis Nodosa;   Takayasu Arteritis;   Primary CNS Vasculitis;   Unclassified Vasculitis
Intervention:
17 Not yet recruiting Magnetic Resonance Imaging of Intracranial Vasculopathies
Condition: CNS Vasculitis
Intervention: Other: Vessel Wall MR imaging
18 Recruiting Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Conditions: Cryoglobulinemic Vasculitis (CV);   Drug-induced Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis (EGPA);   IgA Vasculitis;   Isolated Cutaneous Vasculitis;   Granulomatosis With Polyangiitis (GPA);   Microscopic Polyangiitis (MPA);   Polyarteritis Nodosa (PAN);   Urticarial Vasculitis;   Vasculitis
Intervention:
19 Not yet recruiting Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
Condition: Invasive Pneumococcal Infection
Interventions: Biological: PCV13;   Biological: PPV23;   Drug: Rituximab
20 Recruiting Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Conditions: Autoimmune Disease;   Vascular Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.